Cardiac magnetic resonance: rapid protocol. How much could we evaluate?
DOI:
https://doi.org/10.37615/retic.v7n3a1Downloads
Metrics
References
Kramer CM, Barkhausen J, Bucciarelli-Ducci C, Flamm SD, Kim RJ, et al. Standardized cardiovascular magnetic resonance imaging (CMR) protocols: 2020 update. J Cardiovasc Magn Reson. 2020;22(1):17. https://doi.org/10.1186/s12968-020-00607-1 DOI: https://doi.org/10.1186/s12968-020-00607-1
Menacho-Medina K, Ntusi NAB, Moon JC, Walker JM, Jacob R. Rapid cardiac MRI protocols: feasibility and potential applications. Curr Radiol Rep. 2020;8:2. https://doi.org/10.1007/s40134-020-0344-6 DOI: https://doi.org/10.1007/s40134-020-0344-6
Polacin M, Kapos I, Gastl M, Blüthgen C, Karolyi M, et al. Comparison of 3D and 2D late gadolinium enhancement magnetic resonance imaging in patients with acute and chronic myocarditis. Int J Cardiovasc Imaging. 2021;37(1):305-313. https://doi.org/10.1007/s10554-020-01966-7 DOI: https://doi.org/10.1007/s10554-020-01966-7
Raman SV, Markl M, Patel AR, Bryant J, Allen BD, et al. 30-minute CMR for common clinical indications: a Society for Cardiovascular Magnetic Resonance white paper. J Cardiovasc Magn Reson. 2022;24(1):13. https://doi.org/10.1186/s12968-022-00844-6 DOI: https://doi.org/10.1186/s12968-022-00844-6
Menacho K, Ramirez S, Segura P, Nordin S, Abdel-Gadir A, et al. INCA (Peru) Study: Impact of Non-Invasive Cardiac Magnetic Resonance Assessment in the Developing World. J Am Heart Assoc. 2018;7(17):e008981. https://doi.org/10.1161/JAHA.118.008981 DOI: https://doi.org/10.1161/JAHA.118.008981
Menacho KD, Ramirez S, Perez A, Dragonetti L, Perez de Arenaza D, et al. Improving cardiovascular magnetic resonance access in low- and middle-income countries for cardiomyopathy assessment: rapid cardiovascular magnetic resonance. Eur Heart J. 2022;43(26):2496-2507. https://doi.org/10.1093/eurheartj/ehac035 DOI: https://doi.org/10.1093/eurheartj/ehac035
Abdel-Gadir A, Vorasettakarnkij Y, Ngamkasem H, Nordin S, Ako EA, et al. Ultrafast Magnetic Resonance Imaging for Iron Quantification in Thalassemia Participants in the Developing World: The TIC-TOC Study (Thailand and UK International Collaboration in Thalassaemia Optimising Ultrafast CMR). Circulation. 2016;134(5):432-4. https://doi.org/10.1161/CIRCULATIONAHA.116.022803 DOI: https://doi.org/10.1161/CIRCULATIONAHA.116.022803
Medina KM, Abdel-Gadir A, Ganga K, Ojha V, Pratap S, et al. Use of rapid cardiac magnetic resonance imaging to guide chelation therapy in patients with transfusion-dependent thalassaemia in India: UMIMI study. Eur Heart J Qual Care Clin Outcomes. 2022;8(3):289-297. https://doi.org/10.1093/ehjqcco/qcab089 DOI: https://doi.org/10.1093/ehjqcco/qcab089
Torlasco C, Castelletti S, Soranna D, Volpato V, Figliozzi S, et al. Effective Study: Development and Application of a Question-Driven, Time-Effective Cardiac Magnetic Resonance Scanning Protocol. J Am Heart Assoc. 2022;11(1): e022605. https://doi.org/10.1161/JAHA.121.022605 DOI: https://doi.org/10.1161/JAHA.121.022605
Foley JRJ, Richmond C, Fent GJ, Bissell M, Levelt E, et al. Rapid Cardiovascular Magnetic Resonance for Ischemic Heart Disease Investigation (RAPID-IHD). JACC Cardiovasc Imaging. 2020;13(7):1632-1634. https://doi.org/10.1016/j.jcmg.2020.01.029 DOI: https://doi.org/10.1016/j.jcmg.2020.01.029
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Sara Elizabeth Ramírez Flores
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
RETIC is distributed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) license https://creativecommons.org/licenses/by-nc-nd/4.0 which allows sharing, copying and redistribution of the material in any medium or format, under the following terms:
- Attribution: you must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests that the licensor endorses you or your use.
- Non-commercial: you may not use the material for commercial purposes.
- No Derivatives: if you remix, transform or build upon the material, you may not distribute the modified material.
- No Additional Restrictions: you may not apply legal terms or technological measures that legally restrict others from doing anything permitted by the license.
